STRUCTURAL/SYNTHETIC STUDIES OF BIOACTIVE MARINE AGENTS
海洋生物活性剂的结构/综合研究
基本信息
- 批准号:6019071
- 负责人:
- 金额:$ 10.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-08-01 至 2000-07-31
- 项目状态:已结题
- 来源:
- 关键词:Porifera Tunicata X ray crystallography animal extract antimitotics antineoplastics cell differentiation chemical structure function cyclization drug design /synthesis /production immunomodulators lactams molecular rearrangement nuclear magnetic resonance spectroscopy saltwater environment stereochemistry tubulin
项目摘要
DESCRIPTION: The objectives of this proposal include the structure
determination and total synthesis of novel marine natural products
displaying potent biological activity. Targets are said to include
bistramide A, a tunicate isolate inducing cellular differentiation,
pateamine A, a marine sponge isolate exhibiting immunomodulating
properties, and curacin A, a marine bacterial antimitotic agent which
inhibits tubulin polymerization.
It is reported that bistramide A promises to be a useful new tool for the
study of mechanisms involved in cellular differentiation, a capacity lost
by some cancerous cells and that methods for the preparation of
crystalline derivatives of bistramide A suitable for x-ray analysis are
proposed as a means to determine its relative and absolute
stereochemistry. The principal investigator notes that a convergent,
stereoflexible route is proposed for the enantioselective, total
synthesis of bistramide A and that key features of the synthesis include
an Ireland-Claisen rearrangement and a samarium diiodide mediated,
sequential acyl substitution/redox process. It is indicated that the
synthesis of structural derivatives and a bistramide A affinity matrix
will allow preliminary investigations into the mode of action of these
agents.
The principal investigator states that as a first step towards
understanding how pateamine A exerts its immunomodulating effects, an
initial objective in collaboration with Professor M. Munro (University
of Canterbury. New Zealand) is determination of its relative and
absolute stereochemistry by using a combination of semi-synthesis,
natural product degradation, molecular modeling, and NMR spectroscopy and
that structural verification is to be accomplished by executing a
convergent, enantioselective synthesis of pateamine. It is indicated that
the convergent nature of the synthesis will allow access to significant
quantities of pateamine A and structural derivatives for further
evaluation as potential immunosuppressive agents by Dr. G. Faircloth
(PharmaMar, USA) and for investigations into their mechanism of action.
It is noted that a convergent, enantioselective synthesis of four
diastereomers of curacin A will enable spectroscopic comparison to an
authentic sample for stereochemical determination of this antimitotic
agent. The principal investigator states that a key step in the
synthetic approach includes a novel Stille-type coupling of a
cyclopropyl stannane to a cysteine derived- thiazoline triflate to
prepare the structurally unique cyclopropyl-thiazoline portion of curacin
A and structural variants in this region of the molecule. These
derivatives are to be evaluated for their ability to inhibit tubulin
polymerization by Dr. E. Hamel (National Cancer Institute-NIH). It is
suggested that these investigations may lead to a novel class of
antineoplastic agents that exert their effects via the colchicine
binding site of tubulin in contrast to other known inhibitors of tubulin
polymerization which exert their effects at the vinblastine binding site.
描述:该提案的目标包括结构
新型海洋天然产物的测定与全合成
显示出有效的生物活性。据说目标包括
bistramide A,一种诱导细胞分化的被囊动物分离物,
pateamine A,一种具有免疫调节作用的海洋海绵分离物
特性,以及 curacin A,一种海洋细菌抗有丝分裂剂,
抑制微管蛋白聚合。
据报道,bistramide A有望成为一种有用的新工具
研究细胞分化、能力丧失的机制
由一些癌细胞和制备方法
适用于 X 射线分析的 bistramide A 结晶衍生物有
提议作为确定其相对和绝对的手段
立体化学。首席研究员指出,一个趋同的、
提出了立体柔性路线用于对映选择性、总
bistramide A 的合成,该合成的主要特征包括
爱尔兰-克莱森重排和二碘化钐介导,
顺序酰基取代/氧化还原过程。据表明,
结构衍生物和 bistramide A 亲和基质的合成
将允许对这些行动方式进行初步调查
代理。
首席研究员表示,作为迈向的第一步
了解 pateamine A 如何发挥其免疫调节作用,
与 M. Munro 教授(大学
坎特伯雷。新西兰)是确定其相对和
通过使用半合成的组合进行绝对立体化学,
天然产物降解、分子建模和核磁共振波谱
结构验证是通过执行来完成的
巴巴胺的收敛、对映选择性合成。表明的是
合成的收敛性质将允许获得重要的
大量的巴巴胺A和结构衍生物用于进一步
G. Faircloth 博士评估其作为潜在的免疫抑制剂
(PharmaMar,美国)并研究其作用机制。
值得注意的是,四种物质的会聚、对映选择性合成
curacin A 的非对映异构体将能够与
用于立体化学测定这种抗有丝分裂的真实样品
代理人。首席研究员表示,该研究的关键一步是
合成方法包括一种新颖的 Stille 型耦合
环丙基锡烷转化为半胱氨酸衍生的三氟甲磺酸噻唑啉
制备 Curacin 结构独特的环丙基噻唑啉部分
A 和该分子区域的结构变体。这些
将评估衍生物抑制微管蛋白的能力
由 E. Hamel 博士(美国国家癌症研究所 - NIH)进行聚合。这是
表明这些研究可能会导致一类新的
通过秋水仙碱发挥作用的抗肿瘤药
微管蛋白的结合位点与其他已知的微管蛋白抑制剂相比
聚合作用在长春花碱结合位点发挥作用。
项目成果
期刊论文数量(23)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Total synthesis of the spirocyclic imine marine toxin (-)-gymnodimine and an unnatural C4-epimer.
- DOI:10.1021/ja207385y
- 发表时间:2011-12-14
- 期刊:
- 影响因子:15
- 作者:Kong, Ke;Moussa, Ziad;Lee, Changsuk;Romo, Daniel
- 通讯作者:Romo, Daniel
Functional mimicry revealed by the crystal structure of an eIF4A:RNA complex bound to the interfacial inhibitor, desmethyl pateamine A.
- DOI:10.1016/j.chembiol.2020.12.006
- 发表时间:2021-06-17
- 期刊:
- 影响因子:8.6
- 作者:Naineni SK;Liang J;Hull K;Cencic R;Zhu M;Northcote P;Teesdale-Spittle P;Romo D;Nagar B;Pelletier J
- 通讯作者:Pelletier J
A beta-lactone route to chiral gamma-substituted alpha-amino acids: application to the concise synthesis of (S)-alpha-azidobutyro lactone and a natural amino acid.
- DOI:10.1021/ol017120b
- 发表时间:2002-01
- 期刊:
- 影响因子:5.2
- 作者:R. L. Tennyson;Guillermo S. Cortez;Hector J. Galicia;Charles R. Kreiman;C. Thompson;D. Romo
- 通讯作者:R. L. Tennyson;Guillermo S. Cortez;Hector J. Galicia;Charles R. Kreiman;C. Thompson;D. Romo
Second-generation derivatives of the eukaryotic translation initiation inhibitor pateamine A targeting eIF4A as potential anticancer agents.
- DOI:10.1016/j.bmc.2013.11.046
- 发表时间:2014-01-01
- 期刊:
- 影响因子:3.5
- 作者:Low WK;Li J;Zhu M;Kommaraju SS;Shah-Mittal J;Hull K;Liu JO;Romo D
- 通讯作者:Romo D
Synthesis, characterization, and utility of thermoresponsive natural/unnatural product macroligands for affinity chromatography.
用于亲和色谱的热响应性天然/非天然产物大配体的合成、表征和效用。
- DOI:10.1021/ol062045w
- 发表时间:2006
- 期刊:
- 影响因子:5.2
- 作者:Zhou,Min;Sivaramakrishnan,Ananthapadmanab;Ponnamperuma,Krishan;Low,Woon-Kai;Li,Chunmei;Liu,JunO;Bergbreiter,DavidE;Romo,Daniel
- 通讯作者:Romo,Daniel
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL ROMO其他文献
DANIEL ROMO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL ROMO', 18)}}的其他基金
Pharmacophore-Directed Retrosynthesis Applied to Bioactive Natural Products Informing Mechanism of Action Studies
药效团导向的逆合成应用于生物活性天然产物,为作用研究机制提供信息
- 批准号:
10078959 - 财政年份:2020
- 资助金额:
$ 10.63万 - 项目类别:
Pharmacophore-Directed Retrosynthesis Applied to Bioactive Natural Products Informing Mechanism of Action Studies
药效团导向的逆合成应用于生物活性天然产物,为作用研究机制提供信息
- 批准号:
10389199 - 财政年份:2020
- 资助金额:
$ 10.63万 - 项目类别:
Pharmacophore-Directed Retrosynthesis Applied to Bioactive Natural Products Informing Mechanism of Action Studies
药效团导向的逆合成应用于生物活性天然产物,为作用研究机制提供信息
- 批准号:
10545741 - 财政年份:2020
- 资助金额:
$ 10.63万 - 项目类别:
Pharmacophore-Directed Retrosynthesis Applied to Bioactive Natural Products Informing Mechanism of Action Studies
药效团导向的逆合成应用于生物活性天然产物,为作用研究机制提供信息
- 批准号:
10314044 - 财政年份:2020
- 资助金额:
$ 10.63万 - 项目类别:
New Methods for Simultaneous Arming and SAR Studies of Natural Products
天然产物同时武装和SAR研究的新方法
- 批准号:
7559825 - 财政年份:2008
- 资助金额:
$ 10.63万 - 项目类别:
New Methods for Simultaneous Arming and SAR Studies of Natural Products
天然产物同时武装和SAR研究的新方法
- 批准号:
7693246 - 财政年份:2008
- 资助金额:
$ 10.63万 - 项目类别:
New Methods for Simultaneous Arming and SAR Studies of Natural Products
天然产物同时武装和SAR研究的新方法
- 批准号:
7884268 - 财政年份:2008
- 资助金额:
$ 10.63万 - 项目类别:
New Methods for Simultaneous Arming and SAR Studies of Natural Products
天然产物同时武装和SAR研究的新方法
- 批准号:
7687367 - 财政年份:2008
- 资助金额:
$ 10.63万 - 项目类别:
NOVEL ANTICANCER FATTY ACID SYNTHASE INHIBITORS
新型抗癌脂肪酸合成酶抑制剂
- 批准号:
6759706 - 财政年份:2004
- 资助金额:
$ 10.63万 - 项目类别:
B-Lactones: Bioactive Target and Vehicles for Synthesis
B-内酯:生物活性靶标和合成载体
- 批准号:
7009943 - 财政年份:2004
- 资助金额:
$ 10.63万 - 项目类别:
相似国自然基金
浮游被囊类对海洋上升流生态系统微型食物网的影响
- 批准号:40606033
- 批准年份:2006
- 资助金额:28.0 万元
- 项目类别:青年科学基金项目
脊索动物生殖内分泌的研究
- 批准号:39370100
- 批准年份:1993
- 资助金额:5.5 万元
- 项目类别:面上项目
相似海外基金
APPROACHES TO CHARACTERIZATION OF ANTIINFECTIVE AGENTS
抗感染剂的表征方法
- 批准号:
2886084 - 财政年份:1998
- 资助金额:
$ 10.63万 - 项目类别:
APPROACHES TO CHARACTERIZATION OF ANTIINFECTIVE AGENTS
抗感染剂的表征方法
- 批准号:
6532596 - 财政年份:1998
- 资助金额:
$ 10.63万 - 项目类别:
APPROACHES TO CHARACTERIZATION OF ANTIINFECTIVE AGENTS
抗感染剂的表征方法
- 批准号:
6372593 - 财政年份:1998
- 资助金额:
$ 10.63万 - 项目类别:
APPROACHES TO CHARACTERIZATION OF ANTIINFECTIVE AGENTS
抗感染剂的表征方法
- 批准号:
6168418 - 财政年份:1998
- 资助金额:
$ 10.63万 - 项目类别:
APPROACHES TO CHARACTERIZATION OF ANTIINFECTIVE AGENTS
抗感染剂的表征方法
- 批准号:
2450444 - 财政年份:1998
- 资助金额:
$ 10.63万 - 项目类别: